Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US

Authors:
  • GIGOULD Investigators
    GOULD Investigators
Top Cited Papers
Open Access
Publisher website
Google Scholar
Abstract
Lipid lowering is one of the most effective strategies to reduce cardiovascular morbidity and mortality.1 Clinical benefits of low-density lipoprotein cholesterol (LDL-C) level reduction have been seen in large randomized clinical trials with statins, ezetimibe, and most recently, proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i).1-6

This publication has 20 references indexed in Scilit: